ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer?-Reference-Cited by-同舟云学术

ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer?

Published:2023-02-08 Issue:6 Volume:30 Page:3316-3317
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kepenekian Vahan,Kefleyesus Amaniel,Passot Guillaume,Rousset Pascal,Benzerdjeb Nazim,You Benoit,Peron Julien,Glehen Olivier

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-13214-y.pdf

Reference5 articles.

1. Quenet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256–66. https://doi.org/10.1016/s1470-2045(20)30599-4.

2. Rovers KP, Simkens GA, Punt CJ, van Dieren S, Tanis PJ, de Hingh IH. Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review. Crit Rev Oncol Hematol. 2017;114:53–62. https://doi.org/10.1016/j.critrevonc.2017.03.028.

3. Rovers KP, Bakkers C, Nienhuijs SW, et al. Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases. JAMA Surg. 2021;156(8):710–20. https://doi.org/10.1001/jamasurg.2021.1642.

4. Cremolini C, Antoniotti C, Stein A, et al. Individual patient data meta-analysis of FOLFOXIRI plus bevacizumab versus doublets plus bevacizumab as initial therapy of unresectable metastatic colorectal cancer. J Clin Oncol Official J Am Soc Clin Oncol. 2020;38(28):JCO2001225. https://doi.org/10.1200/jco.20.01225.

5. Fanget F, Kefleyesus A, Peron J, et al. Comparison of neoadjuvant systemic chemotherapy protocols for the curative-intent management of peritoneal metastases from colorectal cancer, regarding morphological response, pathological response, and long-term outcomes—a retrospective study. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13150-x